Germline TERT promoter mutations are rare in familial melanoma

[1]  Thomas M. Keane,et al.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. , 2015, Journal of the National Cancer Institute.

[2]  Y. Zhan,et al.  RE: The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length. , 2014, Journal of the National Cancer Institute.

[3]  J. Malvehy,et al.  Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling. , 2014, Journal of the American Academy of Dermatology.

[4]  Jeffrey E. Lee,et al.  The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length , 2014, Journal of the National Cancer Institute.

[5]  C. Sander,et al.  Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.

[6]  Å. Borg,et al.  High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families , 2014, Journal of Medical Genetics.

[7]  Thomas M. Keane,et al.  POT1 loss-of-function variants predispose to familial melanoma , 2014, Nature Genetics.

[8]  Jianxin Shi,et al.  Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma , 2014, Nature Genetics.

[9]  Richard Durbin,et al.  Estimating telomere length from whole genome sequence data , 2014, Nucleic acids research.

[10]  S. Chanock,et al.  Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations , 2013, PloS one.

[11]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[12]  L. Thomas,et al.  Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants , 2013, Journal of Medical Genetics.

[13]  H. Pass,et al.  BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs , 2012, Journal of Translational Medicine.

[14]  Jeffrey E. Lee,et al.  Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Genetics.

[15]  A. Bowcock,et al.  Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.

[16]  J. Barrett,et al.  Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[17]  B. Ponder,et al.  Telomere length in prospective and retrospective cancer case-control studies. , 2010, Cancer research.

[18]  S. Puig,et al.  Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.

[19]  J. Ko,et al.  Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. , 2006, European journal of cancer.

[20]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.

[21]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[22]  D. Schadendorf,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2022 .